Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q3 2018 · 10-Q
Revenue$2.46B$2.46B+5.6% vs Q3 2017 Net Income-$565.00K-$565.00KN/M vs Q3 2017 EPS Diluted-$0.01-$0.01N/M vs Q3 2017 Gross Profit$352,574,000+16.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$76,256,000−13.5% Free Cash Flowderived$63,583,000−20.1% Margins · derivedGross margin14.3%+1.4 pt vs Q3 2017
Operating margin0.9%−0.4 pt vs Q3 2017
Net margin-0.0%−0.5 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 5, 2018 · 36 d after period end